AUSTERE SYSTEMS
Austere Systems offers application development and maintenance, cloud computing, digital marketing, IT staffing augmentation, training.
AUSTERE SYSTEMS
Industry:
Information Technology Mobile Apps Software Web Development
Founded:
2007-01-01
Address:
Pune, Maharashtra, India
Country:
India
Website Url:
http://www.austeresystems.com
Total Employee:
51+
Status:
Active
Contact:
91-772-008-3881
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Euro Google Maps U.S. Server Location SmtpJS.com
Similar Organizations
Dextro Software Systems
Dextro Software Systems consults in software development, cloud computing, mobile apps, IT staffing and IT solutions.
Mohar Technologies
Mohar Technologies offers IT website and app development solutions, digital marketing, UI/UX design, and mobile apps development.
Webdukes Technologies Pvt. Ltd
Website Design | App Development | Cloud Computing | Digital Marketing | Meanstack | Software Development | Branding
Official Site Inspections
http://www.austeresystems.com Semrush global rank: 7 M Semrush visits lastest month: 944
- Host name: 172.67.212.229
- IP address: 172.67.212.229
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Austere Systems"
Savings Program - SPRAVATO withMe
What is SPRAVATO® (esketamine) CIII nasal spray? SPRAVATO® is a prescription medicine used: Savings Program Medical Claims Pharmacy Claims Payer ID: BIN: GROUP: GROUP:See details»
Esketamine (nasal route) - Side effects & dosage - Mayo Clinic
Sep 1, 2025 Esketamine nasal spray is also used together with an antidepressant taken by mouth, to treat depressive symptoms in patients with major depressive disorder (MDD) with โฆSee details»
Cost-effectiveness of esketamine nasal spray compared to โฆ
Dec 15, 2022 The aim of this study was to estimate the cost-effectiveness of esketamine nasal spray relative to intravenous ketamine for patients with treatment-reโฆSee details»
Esketamine (Spravato) Patient Guide: Benefits, Dosing, and Side โฆ
Jun 17, 2025 This guide is adapted from the clinician guide authored by Sebastián Malleza, M.D., M.Sc. at the Psychopharmacology Institute. For the complete clinical resource, visit: โฆSee details»
SPRAVATO® Affordability & Treatment Support | SPRAVATO® (esketamine โฆ
There may be resources to help with your out-of-pocket medicine costs, even if you donโt have insurance. A Care Navigator can help you explore cost support options. Patient assistance โฆSee details»
Esketamine: Uses, Interactions, Mechanism of Action | DrugBank โฆ
Generic Name Esketamine DrugBank Accession Number DB11823 Background Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness โฆSee details»
SPRAVATO® (esketamine): A Prescription Nasal Spray
Learn about SPRAVATO® CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.See details»
SPRAVATO® Insurance Coverage Questions | SPRAVATO® (esketamine) Nasal Spray
Cost Support & Education Explore our list of common insurance questions below, relating to SPRAVATO ® coverage. Access SPRAVATO ® educational resources like informative FAQs โฆSee details»
Cost-Effectiveness of Esketamine Nasal Spray for Patients With ...
In this decision-analytic modeling analysis incorporating recently released phase 3 clinical trial data (4), we found that esketamine nasal spray is unlikely to be a cost-effective treatment for โฆSee details»
Cost and Spravato: Financial assistance options, savings, more
Aug 22, 2024 Spravato (esketamine) is prescribed to treat certain types of depression. Spravatoโs cost may depend on factors such as your dosage and whether you have health โฆSee details»
How Much Does Spravato Cost? Insurance Coverage & Financial โฆ
For individuals considering Spravato (esketamine nasal spray) for treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal ideation, cost is often a major โฆSee details»
Cost Comparison Table - Pharmacoeconomic Report: Esketamine ...
The comparators presented in the following table have been deemed to be appropriate based on feedback from clinical expert(s). Comparators may be recommended (appropriate) practice or โฆSee details»
Spravato Medicare Coverage Explained | Medicare ABC
Jul 11, 2023 Spravato (esketamine), a nasal spray for treatment-resistant depression, is generally not covered under Medicare Part B, as it is a self-administered medication. However, โฆSee details»
Treatment-Resistant Depression: Cost-Effectiveness of Esketamine Nasal ...
Jul 7, 2020 The use of esketamine nasal spray for the management of patients with treatment-resistant depression is unlikely to be cost-effective at its current US price of $240 per dose, โฆSee details»
Esketamine Nasal Spray vs Quetiapine Extended-Release: โฆ
Jan 27, 2025 Abstract Objective: This post hoc analysis of the ESCAPE-TRD trial compared work productivity loss (WPL) and related costs among patients with treatment-resistant โฆSee details»
Spravato: Uses, side effects, dosage, how to use, cost, and more
Apr 30, 2025 Spravato (esketamine) is a prescription nasal spray that treats depression in adults. Learn about dosage, side effects, and more.See details»
A ketamine nasal spray will be subsidised for - The Conversation
Apr 28, 2025 After May 1, the drug will cost a tiny fraction of its original price. But it canโt be taken at home.See details»
Esketamine | Department of Psychiatry
Intranasal Esketamine (Spravato) is an isolated form of the compound ketamine, which is used as an anesthetic, treatment for chronic pain, and in recent years as a rapid-acting antidepressant. โฆSee details»
Esketamine (Spravato) | National Alliance on Mental Illness (NAMI)
Download PDF Generic name: esketamine (es KET ah meen) Brand name: Spravato® Nasal spray: 56 mg, 84 mg dose kit All FDA warnings are at the end of this fact sheet. Please consult โฆSee details»
Esketamine โ Best Brains And Minds
Esketamine Nasal Spray is delivered at Best Brains and Minds Clinic under the supervision of a nurse, twice a week for the first month. After receiving the treatment, the person must stay in โฆSee details»